Universal Diagnostics SL

We are developing blood tests that detect cancer in its earliest stages so we can transform cancer into a disease that’s preventable and curable. We are developing Signal-X™, a multi-cancer platform able to detect various types of high-burden cancers with high sensitivity and tissue-of-origin specificity. Since 2012, an international, multi-disciplinary highly experienced team focused on cracking cancer’s code. We have built a network of >100 hospitals in the U.S. and across Europe with whom we have recruited >12K samples and work with more than hundred gastrointestinal clinical teams. We are currently running an observational study, USOPTIVAL, for which we are recruiting 1,200 patients at >15 US hospitals.